. One way of approaching this problem interaction, competitive inhibition, noncompetitive inhibition, and would be to develop biologically based dosimetry and uncompetitive inhibition). The metabolic inhibition constant (K i ) toxicity models, such that multiple interactions can be for each binary pair of alkyl benzenes was estimated by fitting the simultaneously accounted for and systematically analyzed binary chemical PBPK model simulations to previously published at any level of complexity. (Sato et al., 1990) , PBPK model for the ternary mixture simulated adequately the bromodichloromethane/chlordecone (Thakore et al., 1991), time course of the venous blood concentrations of TOL, XYL, and and toluene/xylene (Tardif et al., 1993) . These efforts on EBZ in rats exposed to a mixture containing 100 ppm each of binary chemical mixture modeling have led the way in the these solvents. Following the validation of the ternary mixture development of PBPK models for multichemical mixtures model in the rat, it was scaled to predict the kinetics of TOL, (Krishnan et al., 1994). Except for a preliminary, theoreti-XYL, and EBZ in blood and alveolar air of human volunteers cal modeling study involving n-hexane and two of its me- centrations of TOL, XYL, and EBZ that remain within the permissible concentrations for a mixture would not result in biologically To achieve the ultimate goal of developing mechanistic 120
FIG. 1.
Structure of the physiologically based pharmacokinetic (PBPK) model for the ternary mixture of alkyl benzenes [toluene (TOL), m-xylene (XYL), and ethylbenzene (EBZ)]. It consists of three single chemical PBPK models linked via the metabolism term of the liver compartment. C TOL , C XYL , and C EBZ refer to the venous blood concentration of TOL, XYL, and EBZ leaving the liver compartment; K iTX , K iXT , K iEX , K iET , K iXE , and K iTE refer to the constants describing the competitive inhibition of the metabolism of one mixture constituent by another [TOL (T), XYL (X), and EBZ (E)]. RPT, PPT, and RAM refer, respectively, to the richly perfused tissues, poorly perfused tissues, and to the amount of an alkyl benzene metabolized in the liver. V max and K m refer to the maximal velocity of metabolism and Michaelis affinity constant. EBZ) in the rat. In this model, the rat was represented as a network of   TABLE 1 four tissue compartments, namely, liver, adipose tissue, slowly perfused Physiological Parameters Used in the PBPK Models tissues, and richly perfused tissues, interconnected with systemic circulation and a gas-exchange lung (Ramsey and Andersen, 1984) . The tissue Values uptake of chemicals was described as a perfusion-limited process, and the rate of change in the amount of alkyl benzenes in each tissue was Parameters Rat a Human b described with a set of mass balance differential equations (Ramsey and Andersen, 1984 Tardif et al. (1993) .
(cardiac output, alveolar ventilation rate, tissue volumes, and tissue blood b From Arms et al. (1988) ; Kaneko et al. (1991) .
flow rates) were obtained from the literature (Tardif et al., 1993;  (1989) . The rat blood:air and tissue:air partition coefficients of EBZ at the binary level. The present study representing our were estimated by determining its headspace concentration at equilibrium, following the introduction of 0.2 mmol into sealed glass vials (22 ml) initial effort in this regard involved the investigation of containing 1 ml of blood or 0.5 ml of tissue homogenates (1:4 in 0.9% the potential usefulness of PBPK modeling to predict the saline). The headspace concentration of EBZ was determined by injecting pharmacokinetics of the components of a ternary mixture, a 1.0-ml sample with a Tekmar Headspace Autosampler-7000 into a gas based on knowledge of the mechanisms of binary chemical chromatograph (Hewlett-Packard 5890A) equipped with a flame ionization interactions. For the present modeling study, we chose toluene (TOL), m-xylene (XYL), and ethylbenzene (EBZ), which have been reported or postulated to be substrates Tardif et al., 1993; Tassanleyakul et al., 1996) . a Gargas et al. (1989) .
PBPK Modeling of Alkyl Benzenes in the Rat
b Sato (1991) . PBPK modeling of the alkyl benzene mixtures in the rat was accomc Kaneko et al. (1991) . plished in four sequential steps, namely, model representation, model pad Determined experimentally in this study. rametrization, model simulation, and model validation.
e Tardif et al. (1993) . f This study. Based on the best fit of the simulation to the time-course data Model representation. Initially, an individual chemical PBPK model was constructed for each of the three alkyl benzenes (TOL, XYL, and on the venous blood concentration of solvents following single exposures.
FIG. 2.
Comparison of the PBPK model simulations of venous blood concentrations of toluene, m-xylene, and ethyl benzene with experimental data (symbols) obtained in rats exposed for 4 hr to 100 and 200 ppm of each of these solvents alone. Experimental data are from Tardif et al. (1996) , and each data point represents the mean ({SD) of four rats.
detector. The quantitation of EBZ was performed using a glass column (6 refer to the V max and K m for each of the three components, and the metabolic inhibition constant (K i ) for each of the binary chemical pair within the 1 1/8Љ) packed with 10% SP-1000 on Supelcoport 80/100, with nitrogen as the carrier gas (20 ml/min). The oven, injector, and detector temperatures ternary mixture. Whereas the V max and K m for the hepatic metabolism of TOL corresponded to the previously determined values in our laboratory were set at 90, 120, and 200ЊC, respectively.
The biochemical parameters required for the ternary mixture PBPK model (Tardif et al., 1993) , those for XYL and EBZ were estimated by fitting model simulations to experimental data on the venous blood concentration in rats exposed to 100 and 200 ppm of these solvents for 4 hr by inhalation . The K i for each mechanism for each solvent pair was hr exposure to a mixture containing 100 ppm of each of these solvents .
Metabolic Inhibition Constants (K i ) According to Various

Hypotheses of Metabolic Inhibition among Toluene (TOL), m-Xy-
FIG. 3.
Comparison of the PBPK model simulations of venous blood concentrations of toluene (TOL) following a 4-hr inhalation exposure to 100 and 200 ppm TOL alone or in combination with ethylbenzene (EBZ) or m-xylene (XYL). The competitive metabolic inhibition constants used in binary chemical models were obtained following fitting of model simulations to experimental data. Experimental data are from Tardif et al. (1996) , and each data point represents the mean ({SD) of four rats.
FIG. 4.
Comparison of the PBPK model simulations of venous blood concentrations of m-xylene (XYL) following a 4-hr inhalation exposure to 100 and 200 ppm XYL alone or in combination with ethylbenzene (EBZ) or toluene (TOL). The competitive metabolic inhibition constants used in binary chemical models were obtained following fitting of model simulations to experimental data. Experimental data are from Tardif et al. (1996) , and each data point represents the mean ({SD) of four rats. ers), with no recent history of occupational exposure to alkyl benzenes. Prior
PBPK Modeling of Alkyl Benzenes in Humans
to the exposures, they provided their informed consent, following which they The structure of the PBPK model used to describe the kinetics of TOL, underwent a complete medical examination (Tardif et al., 1991) . They were XYL, and EBZ was identical to that developed for the rat. The numerical also instructed to avoid alcohol and medication for a period of 48 hr preceding exposures. They were then exposed for 7 hr/day during 4 different days to values of the species-specific model parameters, however, were replaced with TOL (17 ppm), XYL (33 ppm), or EBZ (33 ppm), alone or in combination. those for humans. The approach involved (i) substituting rat physiological These exposure concentrations correspond to the allowable occupational expoparameters and blood:air partition coefficients with those of humans, (ii) sure concentrations, determined on the basis of the recommendations of ACGIH scaling the V max on the basis of body weight 0.75 , and (iii) keeping all other for solvent mixtures (ACGIH, 1995 (ACGIH, -1996 . model parameters species-invariant. The assumption of metabolic inhibition
The human exposure chamber, solvent vapor generating system, and constants as being species-invariant implies that the nature and magnitude monitoring systems used in the present study have previously been deof the competition involving TOL, XYL, and EBZ for binding to cytochrome scribed (Tardif et al., 1991) . Briefly, the exposures were carried out in a P-450 2E1 does not change between species. This assumption can be accepted dynamic exposure chamber (18.1 m 3 ). Solvent atmospheres were generated as the default since the substrates (TOL, XYL, and EBZ) and the isoform by the introduction of solvent mixed with purified air (4.3 m 3 /min) through (2E1) involved are the same even though the species being considered are 16 diffusers located in the ceiling of the chamber. The concentrations of different (rat vs human). We have successfully used this approach to predict solvents were monitored by injecting an atmospheric sample every 30 min into a gas chromatograph (Tardif et al., 1991) . Additionally, urine samples the kinetics of TOL/XYL mixtures in humans based on competitive inhibition were collected after the first 3 hr of exposure (0-3 hr), at the end of mechanism elucidated in the rat (Tardif et al., 1995) .
exposure (3-7 hr), and during 17 hr following the exposure (7-24 hr). The The human PBPK model for alkyl benzenes was validated with kinetic data urinary concentrations of hippuric acid (major metabolite of TOL), methyl collected during a human volunteer exposure study. This study involved the exposure of four adult males (age, 22-47; body weight, 79-90 kg, nonsmok-hippuric acid (metabolite of XYL), phenyl glyoxylic acid, and mandelic Tardif et al. (1996) , and each data point represents the mean ({SD) of four rats. acid (metabolites of EBZ) were measured by high-pressure liquid chroma- Table 2 . The V max and K m for XYL estimated by fitting model tography (Poggi et al., 1982) and corrected for creatinine content. Addition-simulations to experimental data on its venous blood concentraally, ortho-Cresol, a minor metabolite of TOL, was measured by gas chro-tions were 5.5 mg/hr/kg and 0.22 mg/L (Fig. 2, middle) , and matography (Truchon et al., 1996). for EBZ these values corresponded to 7.3 mg/hr/kg and 1.4
The human PBPK model for alkyl benzenes was used to simulate the time-course of blood and alveolar air concentrations of TOL, XYL, and mg/L, respectively (Fig. 2, bottom) . For TOL, previously pub-EBZ during and following a 7-hr exposure to the TLVs of these substances lished V max and K m values adequately predicted the blood conin mixture (i.e., 17, 33, and 33 ppm, respectively) (ACGIH, 1995 (ACGIH, -1996 . centration profile observed in rats following a four hour inhalaThe model predictions were then compared with the experimental data tion exposure to 100 ppm and 200 ppm of this solvent (Fig. obtained in the human volunteer study. The metabolite concentrations were 2, top). The individual chemical rat PBPK models with these not simulated in the model; however, the experimental data on the urinary levels of metabolites during individual and combined exposures were useful parameter estimates were then linked with each other via hypofor providing additional support to the model predictions of the extent of thetical mechanisms of interaction. Accordingly, the K i for each metabolic inhibition of TOL, XYL, and EBZ in humans during combined of the three simple, hypothetical mechanisms of metabolic inhiexposures.
bition (competitive, noncompetitive, and uncompetitive) was obtained for each binary mixture (XYL/TOL, TOL/EBZ, and
RESULTS
XYL/EBZ) (Table 3) by fitting the model simulations to experi-PBPK Modeling of Alkyl Benzenes in the Rat
mental data on venous blood concentrations of unchanged solvents (Figs. 3-5) . In other words, specifying the K i (from Table  The blood:air and tissue:air partition coefficients of EBZ determined using vial equilibration technique are presented in 3) in the PBPK model along with any of the three correspond- with corresponding experimental data (symbols) obtained in rats exposed for 4 hr to 100 ppm of each of these solvents alone or in combination. Experimental data are from Tardif et al. (1996) , and each data point represents the mean ({SD) of four rats.
FIG. 7. Comparison of the simulations of venous blood concentrations of toluene (TOL), m-xylene (XYL), and ethylbenzene (EBZ) predicted by the individual chemical (solid lines) or a ternary chemical PBPK model (dashed lines)
with corresponding experimental data (symbols) obtained in humans exposed for 7 hr to 17, 33, and 33 ppm, respectively, of these solvents alone or in combination. The ternary model simulations were obtained assuming competitive metabolic inhibition as the mechanism of interaction, based on rat data. Each experimental data point represents the mean ({SD) for four adult male volunteers. *Data points for single and mixed alkyl benzene exposures were significantly different ( p õ 0.05).
ing inhibition mechanisms provides simulations that fit the The ternary chemical mixture PBPK model, incorporating the competitive metabolic inhibition constants for blood kinetic data collected during combined exposures. The value of K i for competitive inhibition was generally closer the various constituent binary chemical mixtures, adequately predicted the venous blood concentrations of TOL, to K m of the respective solvents. Based on this observation, competitive metabolic inhibition was considered to be the XYL, and EBZ observed after a 4-hr exposure of rats to a mixture containing 100 ppm each of the three solvents plausible mechanism of interaction between the various alkyl benzenes. (Fig. 6 ).
FIG. 8. Comparison of the simulations of alveolar air concentrations of toluene (TOL), m-xylene (XYL), and ethylbenzene (EBZ) predicted by the individual chemical (solid lines) or a ternary chemical PBPK model (dashed lines)
with corresponding experimental data (symbols) obtained in humans exposed for 7 hr to 17, 33, and 33 ppm, respectively, of these solvents alone or in combination. The ternary model simulations were obtained assuming competitive metabolic inhibition as the mechanism of interaction, based on rat data. Each experimental data point represents the mean ({SD) for four adult male volunteers. the model simulations and experimental data obtained in
PBPK Modeling of Alkyl Benzenes in Humans
humans indicated that exposure to atmospheric concentraThe human PBPK model, based on the quantitative inter-tions of TOL, XYL, and EBZ that remain within the permisaction mechanism elucidated in the rat (i.e., competitive met-sible concentrations for a mixture (calculated according to abolic inhibition), simulated adequately the blood and alveo-ACGIH (1995) (1996) ) would not result in biologically siglar air concentrations of TOL, XYL, and EBZ observed fol-nificant modifications of their pharmacokinetics. A statistically significant difference (i.e., increase) however, was oblowing individual or combined exposures to 17, 33, and 33 ppm, respectively, of these solvents (Figs. 7 and 8) . Overall, served with respect to the blood concentrations of XYL dur- ing combined exposure (Fig. 7) . Such a significant change would involve the determination of the changes in the disposition of a chemical of interest after exposure to ''compound was not reflected by the alveolar air concentration data collected during the same experiment (Fig. 8) .
X' ' (Constan et al., 1993) . Accordingly, when enzyme inhibition occurs, a modifying factor (i.e., K i ) is incorporated The data on the excretion of the urinary metabolites of TOL, XYL, and EBZ during human exposure to individual into the metabolism term of the chemical of interest. This K i is actually a hybrid constant representing the concentraor mixtures of these chemicals are presented in Table 4 . With the exception of o-cresol and phenyl glyoxylic acid tion and the affinity of the true inhibitor(s) which is (are) not known in this instance. Since the potency, identity, and during the first 3 hr of exposure, the amount of metabolites excreted during different time intervals was not significantly kinetics of individual inhibitors in the mixture are not known, this kind of an empirical PBPK model for chemical different between individual and combined human exposures to alkyl benzenes. mixtures may not be useful for conducting extrapolations (e.g., high dose to low dose extrapolation particularly when the proportions of the mixture constituents change).
DISCUSSION
The various toxicokinetic extrapolations essential within the context of the dose-response assessment of chemical Modeling the pharmacokinetics of the components of mixtures may be conducted with a more complex PBPK complex chemical mixtures is a difficult task, since complimodel, as the one developed in this study. The present apcations arise from the possibility that a third or fourth chemiproach involves the modeling of each component of the cal might alter further the kinetics of interacting chemical mixture plus the possible interactions among the compopairs in the mixture. The principal reason for not considering nents. The most important implication of this modeling exerdata on chemical interactions in risk assessments appears to cise is that the kinetics of the components of complex mixbe related to the state of our knowledge with respect to the tures can be predicted only with information on binary chempredictability of the effects of additional chemicals on each ical interactions. interacting pair within a complex mixture. Such predictabil-
The ability of PBPK models to extrapolate the extent/ ity can only be achieved by understanding the mechanism magnitude of a metabolic interaction from binary mixtures of interaction of each pair, and by interconnecting the interto more complex mixtures arises from the very nature and acting chemicals within a biological modeling framework.
basis of these models. This aspect can be explained with a The present study is an example of how these phenomena hypothetical example. Let's consider a binary chemical mixin a ternary chemical mixture can, relatively easily, be deture AB in which there is a competition between the constitscribed within PBPK models. PBPK modeling framework, all one needs to do is to include becomes evident. Once we describe the effect of C on B, this would result in a change in the rate of B metabolized the values of K i for the interaction between C and A, and C and B, as has been done in the present study. There is still and therefore its concentration in the venous blood leaving liver (Cvl B ). The C vlB is the numerator of the term representthe question of how the addition of C alters the way B interacts (i.e., competes in this example) with A. This is ing the inhibitory effect of B on A (1 / C vlB /K iB,A ). Since exposure to chemical C modifies C vlB , this then translates actually where the unique usefulness of PBPK modeling in a modification of the potency of the interactive effect of binary interactions. Based on the same analogy, it should be possible to predict the influence of the addition of another B on A. Similarly, C may also affect the concentration of A, which then would result in a change in the magnitude of substrate for P-450 2E1 to this ternary mixture, and so forth.
Logically, the present modeling approach should be applicable the interactive effect of A on B. This is the basis with which the PBPK model developed in the present study successfully to mixtures of any complexity, invoking various kinds of mechanisms of interactions among its components. Of course, the pressimulated the kinetics of alkyl benzenes in a ternary mixture, taking into account the impact of the occurrence of various ent study was limited to a ternary mixture, in which all compo-nents compete for the same isoenzyme for metabolism. This be obtained with a PBPK modeling framework, and that binary chemical interaction data are fundamental for the consimple prototype study demonstrates that the kinetics of the struction of mechanistic PBPK models for complex mixcomponents present in complex chemical mixtures can be pretures. In light of these observations, we feel that research dicted by taking into account the inhibition constants for each efforts toward the conduct of descriptive and mechanistic interacting chemical pair, determined separately. For simulating studies of binary chemical interactions should be renewed the kinetics and dynamics of the components of complex mixfor making real advances in the areas of predictive toxicoltures then, data on the quantitative nature of the mechanism of ogy and risk assessment of complex chemical mixtures. binary interactions among the mixture components are alone needed. Based on mechanistic considerations, there should not be a need to conduct kinetic/dynamic studies with intermediary- into PBPK/PD models.
Hypothesizing/determining the exact nature of mechanism of interaction may not be easy/feasible in all cases. Even REFERENCES when certain plausible mechanism(s) can be hypothesized, American Conference of Governmental Industrial Hygienists (ACGIH) as done in the present study, there is still the question of (1995 ). 1995 whether a particular mechanism is the one responsible for adequately. In such cases, discriminating one mechanism
